ASHLYN HINES: Open Payments
NPI 1528721024 · MARRERO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,435 in 122 payments from 19 companies in 2025. Trend: 2023 $1,544 · 2024 $1,876 · 2025 $2,435
Food & beverage: $2,435
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $980 |
| Phathom Pharmaceuticals, Inc. | 7 | $170 |
| Ardelyx, Inc. | 6 | $166 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $164 |
| GENZYME CORPORATION | 3 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $142 |
| Janssen Scientific Affairs, LLC | 1 | $124 |
| Celltrion USA Inc. | 6 | $118 |
| Regeneron Healthcare Solutions, Inc. | 3 | $97 |
| Janssen Biotech, Inc. | 5 | $76 |
Products named: SKYRIZI, RINVOQ, DUPIXENT, TREMFYA, VOQUEZNA, IBSRELA, XIFAXAN, ENTYVIO.
Industry payments across LA — which companies pay providers there.
